Literature DB >> 8448878

Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene.

M Hahn, J Serth, R Fislage, H Wolfes, E Allhoff, V Jonas, A Pingoud.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8448878

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  15 in total

1.  Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

Authors:  A Misra; P Chattopadhyay; A K Dinda; C Sarkar; A K Mahapatra; S E Hasnain; S Sinha
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.

Authors:  M Saegusa; Y Takano; Y Kamata; J Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Authors:  Judy Mouchawar; Christopher Korch; Tim Byers; Todd M Pitts; Efang Li; Margaret R E McCredie; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

4.  Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

Authors:  José Luis Soto Martínez; Carmen M Cabrera Morales; Sabio Serrano Ortega; Miguel Angel López-Nevot
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

5.  Allelic loss at TP53 in metastatic human endometrial carcinomas.

Authors:  Wiktor Szewczuk; Danuta Skomra; Marek Cybulski; Dorota Przadka-Rabaniuk; Agata Filip; Maciej Jóźwik; Piotr Olcha; Albert Roessner; Andrzej Semczuk
Journal:  Clin Exp Metastasis       Date:  2009-06-30       Impact factor: 5.150

6.  Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings.

Authors:  M Saegusa; I Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

7.  Polymorphism of the pentanucleotide repeat d(AAAAT) within intron 1 of the human tumor suppressor gene p53 (17p13.1).

Authors:  M Hahn; R Fislage; A Pingoud
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

8.  p53 and p16INK4A mutations during the progression of glomus tumor.

Authors:  S Güran; E T Tali
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

9.  Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.

Authors:  Faith Pangilinan; Kerry Geiler; Jessica Dolle; James Troendle; Deborah A Swanson; Anne M Molloy; Marie Sutton; Mary Conley; Peadar N Kirke; John M Scott; James L Mills; Lawrence C Brody
Journal:  Am J Med Genet A       Date:  2008-10-15       Impact factor: 2.802

10.  CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.

Authors:  Ranjan Chrisanthar; Stian Knappskog; Erik Løkkevik; Gun Anker; Bjørn Østenstad; Steinar Lundgren; Elisabet O Berge; Terje Risberg; Ingvil Mjaaland; Lovise Maehle; Lars Fredrik Engebretsen; Johan Richard Lillehaug; Per Eystein Lønning
Journal:  PLoS One       Date:  2008-08-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.